Clinical characterization of a cohort of patients treated for systemic lupus erythematosus in Colombia: A retrospective study.
Jorge Enrique Machado-AlbaManuel E Machado-DuqueAndrés Gaviria-MendozaCarolina Duarte-ReyAndrés González-RangelPublished in: PloS one (2023)
Systemic lupus erythematosus generates an important economic and morbidity burden for the Colombian health system. Systemic lupus erythematosus outpatient attention costs in the observation year were mainly determined by drug therapy (especially biologics), medical visits and laboratory tests. New studies addressing the rate of exacerbations, long-term follow-up or costs related to hospital care are recommended.
Keyphrases
- systemic lupus erythematosus
- disease activity
- healthcare
- chronic obstructive pulmonary disease
- cystic fibrosis
- palliative care
- quality improvement
- adverse drug
- working memory
- rheumatoid arthritis
- pain management
- risk factors
- drug induced
- chronic pain
- acute care
- case control
- affordable care act
- smoking cessation
- bone marrow
- replacement therapy